Epicutaneous immune modulation with Bet v 1 plus R848 suppresses allergic asthma in a murine model-Reference-Cited by-同舟云学术

Epicutaneous immune modulation with Bet v 1 plus R848 suppresses allergic asthma in a murine model

Published:2013-12-13 Issue:3 Volume:69 Page:328-337
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Siebeneicher S.¹,Reuter S.²,Krause M.¹,Wangorsch A.³,Maxeiner J.²⁴,Wolfheimer S.³,Schülke S.³,Naito S.⁵,Heinz A.²,Taube C.⁶,Vieths S.³,Scheurer S.³,Toda M.¹

Affiliation:

1. Junior Research Group 1 ‘Experimental Allergy Models’; Paul-Ehrlich-Institut; Langen Germany

2. The III Medical Department; University Hospital Mainz; Mainz Germany

3. Division of Allergology; Paul-Ehrlich-Institut; Langen Germany

4. Asthma Core Facility; The Research Centre Immunology (FZI); University Hospital Mainz; Mainz Germany

5. Division of Quality Assurance; The National Institute of Infectious Diseases; Tokyo Japan

6. Department of Pulmonology; Leiden University Medical Center; Leiden the Netherlands

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference43 articles.

1. Allergen immunotherapy;Frew;J Allergy Clin Immunol,2010

2. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile;Calderón;Allergy,2012

3. Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy?;Senti;Allergy,2011

4. Epicutaneous immunotherapy on intact skin using a new delivery system in a murine model of allergy;Mondoulet;Clin Exp Allergy,2010

5. Epicutaneous immunotherapy results in rapid allergen uptake by dendritic cells through intact skin and downregulates the allergen-specific response in sensitized mice;Dioszeghy;J Immunol,2011

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transdermally delivered tolerogenic nanoparticles induced effective immune tolerance for asthma treatment;Journal of Controlled Release;2024-02

2. Chemical therapies, immunotherapy, and new treatment strategies for allergic asthma;Allergic Asthma: Immunopathogenesis;2024

3. Influence of antigen density and TLR ligands on preclinical efficacy of a VLP‐based vaccine against peanut allergy;Allergy;2023-10-10

4. The next generation virus‐like particle platform for the treatment of peanut allergy;Allergy;2023-03-29

5. A flagellin-conjugate protein induces dual NLRC4- and NLRP3-inflammasome activation which modulates inflammatory cytokine secretion from macrophages;Frontiers in Immunology;2023-03-21